Cargando…
CYP1A2 polymorphism may contribute to agomelatine-induced acute liver injury: Case report and review of the literature
RATIONALE: Liver function monitoring is recommended when agomelatine is prescribed, although liver enzymes are not considered predictive biomarkers. Most patients present with acute liver injury, with only a few presenting with levels of liver enzymes that are over 30 times the upper limit of normal...
Autores principales: | Wang, Shushan, Xu, Qing, Qu, Kankan, Wang, Jun, Zhou, Zhenhe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545369/ https://www.ncbi.nlm.nih.gov/pubmed/34766583 http://dx.doi.org/10.1097/MD.0000000000027736 |
Ejemplares similares
-
Early intervention of acute liver injury related to venlafaxine: A case report
por: Fang, Lin, et al.
Publicado: (2021) -
Genetic polymorphism analysis of cytochrome P4502E1 (CYP2E1) in a Chinese Tibetan population
por: Wang, Li, et al.
Publicado: (2017) -
Network pharmacology integrated with molecular docking technology to reveal the potential mechanism of Shuganfang against drug-induced liver injury
por: Wang, Ying, et al.
Publicado: (2023) -
Drug-induced liver injury in COVID-19 patients during hospitalization
por: Chen, Ying, et al.
Publicado: (2023) -
Methimazole-induced liver injury overshadowed by methylprednisolone pulse therapy: Case report
por: Abramavicius, Silvijus, et al.
Publicado: (2017)